Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Sun Pharmaceutical Industries Ltd.
NSE: SUNPHARMA
|
BSE: 524715
|
ISIN: INE044A01036
|
Industry: Pharmaceuticals
|
Mid-range Performer
1648.6000
28.40
(
1.75
%)
NSE
Sep 18, 2025
15:31 PM
Volume:
1.8M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Sun Pharmaceutical Industries Ltd.
31 Jul 2021
1648.60
1.75%
Top headlines: Sun Pharma's strong Q1 show, India-China military talks
Business Standard
Business Standard brings to you the top headlines on Saturday
Sun Pharmaceutical I.. has an
average target
of 2050.25 from 8 brokers.
Sun Pharma posts 1,444-cr Q1 net
Business Line |
30 Jul 2021
9 more
Sun Pharma: Strong Q1 show, settlement of antitrust case pleases investors
Business Standard |
30 Jul 2021
Market Movers: Two factors that triggered big spike in Sun Pharma
Economic Times |
30 Jul 2021
Sun Pharma Returns To Profit In Q1, Stock Climbs 10% To New 52-Week High
NDTV Profit |
30 Jul 2021
Sun Pharma beats estimates in Q1, shares post biggest gain in over a year
livemint |
30 Jul 2021
Sun Pharma reports net profit of Rs 1,444 crore in Q1
Business Today |
30 Jul 2021
Sun Pharma posts Rs 1,444.17-crore net profit in June quarter
Moneycontrol |
30 Jul 2021
Sun Pharma share price locked in 10% upper circuit on turning profitable in Q1FY22
Moneycontrol |
30 Jul 2021
Sun Pharma rallies 9%, hits over 4-year high on strong June quarter results
Business Standard |
30 Jul 2021
Sun Pharma posts consolidated net profit of Rs 1,444 crore in Q1
Business Standard |
30 Jul 2021
More from Sun Pharmaceutical Industries Ltd.
Recommended
Market closes higher, Ugro Capital gets RBI nod to acquire Profectus Capital
Trendlyne Marketwatch |
18 Sep 2025, 04:03PM
Bull run fizzles out: Multibagger count in Indian equities falls
The Baseline |
18 Sep 2025, 03:38PM
Change is hard, and some Indian pharma companies are embracing it better than others
|
09 Aug 2022